Literature DB >> 28769495

ROLE OF HAEMATOPOIETIC GROWTH FACTORS IN MEDICINE.

Vivek Srivastava1, Rajat Kumar2.   

Abstract

Year:  2017        PMID： 28769495      PMCID： PMC5531121          DOI： 10.1016/S0377-1237(17)30727-X

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  11 in total

Review 1.  Progress in understanding the pathogenesis of the anemia of chronic disease.

Authors:  R T Means; S B Krantz
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

Review 2.  Indications and guidelines for the use of hematopoietic growth factors.

Authors:  L T Goodnough; K C Anderson; S Kurtz; T A Lane; P T Pisciotto; M H Sayers; L E Silberstein
Journal:  Transfusion       Date:  1993 Nov-Dec       Impact factor: 3.157

3.  Hematopoietic growth factors in hematological malignancies.

Authors:  R Kumar; R R Rao; S Ranjan
Journal:  J Assoc Physicians India       Date:  1995

4.  Role of growth factors in hastening hematopoietic recovery following HLA matched sibling allogeneic bone marrow transplantation.

Authors:  P M Parikh; S Kulkarni; G Kapoor; P S Sastry; T K Saikia; R Gopal; P A Kurkure; C N Nair; S K Pai; V R Pai
Journal:  J Assoc Physicians India       Date:  1995-06

5.  Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer.

Authors:  M Fanucchi; J Glaspy; J Crawford; J Garst; R Figlin; W Sheridan; D Menchaca; D Tomita; H Ozer; L Harker
Journal:  N Engl J Med       Date:  1997-02-06       Impact factor: 91.245

Review 6.  Recombinant human erythropoietin and the anemia of cancer.

Authors:  J L Spivak
Journal:  Blood       Date:  1994-08-15       Impact factor: 22.113

7.  Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.

Authors:  J H Antin; B R Smith; W Holmes; D S Rosenthal
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

8.  Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.

Authors:  J Crawford; H Ozer; R Stoller; D Johnson; G Lyman; I Tabbara; M Kris; J Grous; V Picozzi; G Rausch
Journal:  N Engl J Med       Date:  1991-07-18       Impact factor: 91.245

9.  Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.

Authors:  D J Weisdorf; C M Verfaillie; S M Davies; A H Filipovich; J E Wagner; J S Miller; J Burroughs; N K Ramsay; J H Kersey; P B McGlave
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

10.  A phase I study of sequential versus concurrent interleukin-3 and granulocyte-macrophage colony-stimulating factor in advanced breast cancer patients treated with FLAC (5-fluorouracil, leucovorin, doxorubicin, cyclophosphamide) chemotherapy.

Authors:  J A O'Shaughnessy; D J Venzon; M Gossard; M H Noone; A Denicoff; A Tolcher; D Danforth; J Jacobson; P Keegan; L Miller; C Chow; B Goldspiel; K H Cowan
Journal:  Blood       Date:  1995-10-15       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.